Omeprazole, Helicobacter Pylori Status, and Alterations in the Intragastric Milieu Facilitating Bacterial N-nitrosation
Overview
Affiliations
Background & Aims: Omeprazole produces greater acid inhibition in Helicobacter pylori-positive than -negative subjects. We investigated whether this is accompanied by more profound changes in the intragastric milieu that facilitates bacterial synthesis of N-nitroso compounds.
Methods: Gastric juice pH; nitrite, ascorbic acid, and total vitamin C concentrations; and colonization by other bacteria were examined before and during omeprazole treatment in subjects with and without H. pylori infection. Studies were performed in the fasting state and after consumption of 2 mmol nitrate (equivalent to a salad meal).
Results: Before omeprazole, H. pylori-positive and -negative subjects were similar for all parameters. During omeprazole, H. pylori-positive subjects had a higher intragastric pH (7.8 vs. 3.0; P < 0.00001) and greater colonization with non-H. pylori species (5 x 10(7) vs. 5 x 10(5) CFU/mL; P < 0.05). These bacteria included nitrosating species. During omeprazole treatment, H. pylori-positive subjects had higher intragastric nitrite levels after the nitrate meal (median area under the concentration/time curve, 12,450 vs. 4708 micromol/L. min; P = 0.04). Omeprazole lowered intragastric vitamin C levels in H. pylori-positive but not -negative subjects (1.8 vs. 3.4 microg/mL, respectively; P = 0.02).
Conclusions: In H. pylori-positive subjects, omeprazole produces disturbances in intragastric nitrite, vitamin C, and bacterial colonization that facilitate bacterial N-nitrosation. This may place them at increased risk of mutagenesis and carcinogenesis.
Exploring the Link between , Gastric Microbiota and Gastric Cancer.
Sgamato C, Rocco A, Compare D, Priadko K, Romano M, Nardone G Antibiotics (Basel). 2024; 13(6).
PMID: 38927151 PMC: 11201017. DOI: 10.3390/antibiotics13060484.
Zhou C, Bisseling T, van der Post R, Boleij A Comput Struct Biotechnol J. 2023; 23:186-198.
PMID: 38075398 PMC: 10704269. DOI: 10.1016/j.csbj.2023.11.053.
Inflammatory microenvironment in gastric premalignant lesions: implication and application.
Zhang S, Shen Y, Liu H, Zhu D, Fang J, Pan H Front Immunol. 2023; 14:1297101.
PMID: 38035066 PMC: 10684945. DOI: 10.3389/fimmu.2023.1297101.
From nitrate to NO: potential effects of nitrate-reducing bacteria on systemic health and disease.
Liu H, Huang Y, Huang M, Wang M, Ming Y, Chen W Eur J Med Res. 2023; 28(1):425.
PMID: 37821966 PMC: 10566198. DOI: 10.1186/s40001-023-01413-y.
Risk factors associated with gastric malignancy during chronic Infection.
Seeger A, Ringling M, Zohair H, Blanke S Med Res Arch. 2023; 8(3).
PMID: 37655156 PMC: 10470974. DOI: 10.18103/mra.v8i3.2068.